Bifogade filer
Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OAX Equities |
Sektor | Hälsovård |
Industri | Medicinteknik |
2024-06-03 10:20:35
Oslo, 3 June 2024 - Observe Medical ASA ("the Company" or "Observe Medical")
continues to see positive momentum in the re-adoption of its UnoMeterT brand of
medical devices into NHS and across private hospitals in the United Kingdom and
Ireland.
Building on previous announcements, Observe Medical confirms that since the
start of 2024, UnoMeterT products have been delivered to over 30 hospitals
within 11 NHS Trusts in England. UnoMeterT 500 (urinemeter) and UnoMeterT
AbdopressureT (IAP) are experiencing strong demand, further solidified by their
inclusion on both the English and Scottish Urology Frameworks.
Positive news continues in Ireland as well, with UnoMeterT products delivered to
the National Drugs Catalogue (NDC) and anticipated availability in hospitals
within days. This widespread reacceptance reflects the ongoing enthusiasm from
clinicians, nurses, and end-users who value the effectiveness of UnoMeterT
devices.
For further information, please contact:
Jørgen Mann, Interim CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.
The Company is headquartered in Oslo, Norway.
Further information is available at www.observemedical.com.